Pancreatic Cancer Research

ResearcherOsaka City UniversityActive in the last 2 years

Masakazu Yashiro

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-5743-7228; OpenAlex author ID A5025145326, A5089607790. Sources: OpenAlex.

Their work

Papers
7 (first author 2, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
15
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: none · 2016: 2 papers · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 2 papers

Papers 7

  1. Deep Learning on H&E Pathology Images Predicts KRAS and TP53 Mutations in Pancreatic Adenocarcinoma: A Multicenter Study. Last author DOI 10.3390/diseases14070249↗
  2. The Significance of Somatic Variants Involved in the Development of Pancreatic Cancer in Patients with HBOC-Associated Germline Variants. Last author DOI 10.3390/genes17091146↗
  3. Optimal Organ for Patient-derived Xenograft Model in Pancreatic Cancer and Microenvironment that Contributes to Success. Co-author DOI 10.21873/anticanres.15718↗
  4. Establishment of a Liver Transplant Patient-derived Tumor Xenograft (PDX) Model Using Cryopreserved Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.21873/anticanres.14234↗
  5. Establishment and characterization of new cell lines of anaplastic pancreatic cancer, which is a rare malignancy: OCUP-A1 and OCUP-A2. Co-author DOI 10.1186/s12885-016-2297-y↗
  6. Pancreatic Fibroblasts Stimulate the Motility of Pancreatic Cancer Cells through IGF1/IGF1R Signaling under Hypoxia. First author DOI 10.1371/journal.pone.0159912↗
  7. IGF-1 receptor and IGF binding protein-3 might predict prognosis of patients with resectable pancreatic cancer. First author DOI 10.1186/1471-2407-13-392↗

Closest collaborators

The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Dongheng Ma · 2 shared papers, 2026 · strength 0.72
  2. Kenjiro Kimura · 5 shared papers, 2013–2022 · strength 0.37
  3. Ryosuke Amano · 5 shared papers, 2013–2022 · strength 0.37
  4. Koki Uchiyama · 1 shared paper, 2026 · strength 0.29
  5. Hiroji Shinkawa · 2 shared papers, 2020–2022 · strength 0.23
  6. Ryota Tanaka · 2 shared papers, 2020–2022 · strength 0.23
  7. Shoji Kubo · 2 shared papers, 2020–2022 · strength 0.23
  8. Kohei Nishio · 2 shared papers, 2016–2022 · strength 0.19
  9. Sadaaki Yamazoe · 2 shared papers, 2016–2020 · strength 0.15
  10. Masaichi Ohira · 2 shared papers, 2016–2020 · strength 0.15
  11. Kosei Hirakawa · 3 shared papers, 2013–2016 · strength 0.15
  12. Shimpei Eguchi · 1 shared paper, 2022 · strength 0.13
  13. Toshiki Hirakawa · 2 shared papers, 2013–2016 · strength 0.09
  14. Akihiro Murata · 2 shared papers, 2013–2016 · strength 0.09
  15. Kotaro Miura · 1 shared paper, 2016 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.